Dynamk Capital

Dynamk Capital is a venture capital firm based in New York, established in 2015, that focuses on investing in innovative life science companies. The firm targets early and growth stage businesses developing tools, technologies, and services essential for the discovery, development, and production of life-saving therapies. By partnering with visionary leaders in healthcare, Dynamk Capital aims to support market-defining ideas that enhance therapeutic development, improve patient access, and reduce costs. The firm's investment strategy encompasses healthcare devices, supplies, and the broader life sciences sector, with a geographic focus on the United States, Europe, and Canada.

Jessica Davis

Principal

Daniella Kranjac

Founding Partner

Gustavo Mahler

Venture Partner

Reinhard Vogt

Partner

Past deals in Vermont

Vernal Biosciences

Venture Round in 2022
Vernal Biosciences is an mRNA manufacturing company that provides high purity mRNA, from concept to clinical trials, on a transactional basis.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.